OPTOMED.HE
Strong SellSinkerOptomed Oyj · Healthcare · Finland · $59M · Avg Vol: $83K/d
Sinker: Weak, expensive and falling. Nothing here to keep it afloat.
ABOUT OPTOMED OYJ
Read
Optomed Oyj is a medical technology company specializing in handheld fundus cameras and artificial intelligence-based screening software for eye diseases. The company is a global market leader in portable retinal imaging, enabling cost-effective diabetic retinopathy screening in primary care settings. Its growth is driven by proprietary optical technology and integrated AI diagnostics that streamline clinical workflows.
FINANCIAL SUMMARY (EUR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.7M | 15.1M | 15.0M | 17.1M | 5.3% | 16.2M | 17.6M | 20.6M | 9.8% |
| EPS (EUR) | -0.37 | -0.27 | -0.29 | -0.34 | — | -0.28 | -0.16 | -0.11 | — |
| Shares | 16.2M | 17.8M | 19.7M | 21.4M | +32.6% | 21.5M | — | — | — |
| Debt | 6.7M | 4.9M | 3.8M | 2.7M | -26.2% | 2.4M | — | — | — |
| Equity | 20.3M | 20.4M | 23.6M | 24.0M | 5.7% | — | — | — | — |
| Op CF | -2.4M | -0.6M | -1.6M | -2.5M | — | -2.9M | — | — | — |
| Inv CF | -3.0M | -2.4M | -2.1M | -2.4M | — | — | — | — | — |
| Fin CF | 7.0M | 1.6M | 7.1M | 4.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OPTOMED.HE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OPTOMED.HE | Optomed Oyj(you) | $59M | 16 | Strong Sell |
| HEALTH.HE | Nightingale Health Oyj | $65M | 13 | Strong Sell |
| AIFORIA.HE | Aiforia Technologies Oyj | $74M | 3 | Strong Sell |
| HRTIS.HE | Herantis Pharma Oyj | $51M | 5 | Strong Sell |
| NXTMH.HE | Nexstim Plc | $79M | 27 | Sell |
| MODU.HE | Modulight Oyj | $51M | 32 | Sell |
| FARN.L | Faron Pharmaceuticals Oy | $95M | 7 | Strong Sell |
| NANOFH.HE | Nanoform Finland Oyj | $86M | 31 | Sell |
| REG1V.HE | Revenio Group Oyj | $435M | 44 | Hold |
| ORIOLA.HE | Oriola Oyj | $191M | 67 | Buy |
Peer medians: ROE -9.5% · P/E 19.5x · Gross margin 66.9%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.